Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Globus Medical, Inc. GMED

Full chart Compare
Set alert

Price alert · GMED

All alert types
81.44 USD -5.66 (-6.50%)

At closeNov 5, 2026, 6:58 PM EST

79.29 -2.15 -2.64%

After hours · Nov 5, 6:58 PM ET

79.63 Day range 88.10
60.36 52-week range 101.40
YTD
-6.72%
1 year
+32.40%

Financial health

Altman Z-Score

11.49 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

A+4 / 5 overall

  • DCF 5
  • Return on Equity 4
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 3
  • P/B 3

Valuation

P/E 21.9×
FY 2016: 22.8×FY 2017: 36.7×FY 2018: 27.1×FY 2019: 37.5×FY 2020: 62.7×FY 2021: 48.8×FY 2022: 39.3×FY 2023: 48.9×FY 2024: 109×FY 2025: 21.9×
FY 2016 5y median 48.8× FY 2025
P/S 4.0×
FY 2016: 4.2×FY 2017: 6.2×FY 2018: 5.9×FY 2019: 7.4×FY 2020: 8.1×FY 2021: 7.6×FY 2022: 7.3×FY 2023: 3.8×FY 2024: 4.5×FY 2025: 4.0×
FY 2016 5y median 4.5× FY 2025
P/B 2.6×
FY 2016: 2.9×FY 2017: 4.1×FY 2018: 3.6×FY 2019: 4.2×FY 2020: 4.3×FY 2021: 4.2×FY 2022: 4.0×FY 2023: 1.5×FY 2024: 2.7×FY 2025: 2.6×
FY 2016 5y median 2.7× FY 2025
P/FCF 20.0×
FY 2016: 18.1×FY 2017: 36.5×FY 2018: 34.7×FY 2019: 57.7×FY 2020: 47.6×FY 2021: 33.2×FY 2022: 71.5×FY 2023: 36.5×FY 2024: 27.7×FY 2025: 20.0×
FY 2016 5y median 33.2× FY 2025
EV/EBITDA 12.8×
FY 2016: 11.9×FY 2017: 18.7×FY 2018: 18.7×FY 2019: 24.6×FY 2020: 34.7×FY 2021: 26.7×FY 2022: 24.0×FY 2023: 17.5×FY 2024: 23.2×FY 2025: 12.8×
FY 2016 5y median 23.2× FY 2025
EV/Sales 3.9×
FY 2016: 4.1×FY 2017: 6.0×FY 2018: 5.7×FY 2019: 7.2×FY 2020: 7.8×FY 2021: 7.4×FY 2022: 7.2×FY 2023: 3.9×FY 2024: 4.4×FY 2025: 3.9×
FY 2016 5y median 4.4× FY 2025
FCF Yield 5.0%
FY 2016: 5.5%FY 2017: 2.7%FY 2018: 2.9%FY 2019: 1.7%FY 2020: 2.1%FY 2021: 3.0%FY 2022: 1.4%FY 2023: 2.7%FY 2024: 3.6%FY 2025: 5.0%
FY 2016 5y median 3.0% FY 2025

Profitability

Gross Margin 67.4%
FY 2016: 76.1%FY 2017: 76.3%FY 2018: 77.6%FY 2019: 77.1%FY 2020: 72.4%FY 2021: 75.0%FY 2022: 74.2%FY 2023: 65.1%FY 2024: 58.9%FY 2025: 67.4%
FY 2016 5y median 67.4% FY 2025
Operating Margin 16.3%
FY 2016: 27.3%FY 2017: 25.4%FY 2018: 23.7%FY 2019: 21.9%FY 2020: 14.1%FY 2021: 17.9%FY 2022: 22.3%FY 2023: 8.5%FY 2024: 6.6%FY 2025: 16.3%
FY 2016 5y median 16.3% FY 2025
Net Margin 18.3%
FY 2016: 18.5%FY 2017: 16.9%FY 2018: 21.9%FY 2019: 19.8%FY 2020: 13.0%FY 2021: 15.6%FY 2022: 18.6%FY 2023: 7.8%FY 2024: 4.1%FY 2025: 18.3%
FY 2016 5y median 15.6% FY 2025
ROE 11.8%
FY 2016: 12.5%FY 2017: 11.1%FY 2018: 13.2%FY 2019: 11.1%FY 2020: 6.8%FY 2021: 8.6%FY 2022: 10.3%FY 2023: 3.1%FY 2024: 2.5%FY 2025: 11.8%
FY 2016 5y median 8.6% FY 2025
ROIC 8.8%
FY 2016: 12.1%FY 2017: 10.4%FY 2018: 11.7%FY 2019: 9.9%FY 2020: 5.8%FY 2021: 7.8%FY 2022: 9.3%FY 2023: 2.1%FY 2024: 2.9%FY 2025: 8.8%
FY 2016 5y median 7.8% FY 2025
ROA 10.1%
FY 2016: 11.2%FY 2017: 10.0%FY 2018: 12.0%FY 2019: 10.1%FY 2020: 6.1%FY 2021: 7.6%FY 2022: 9.2%FY 2023: 2.4%FY 2024: 2.0%FY 2025: 10.1%
FY 2016 5y median 7.6% FY 2025

Growth (YoY)

Revenue 16.7%
FY 2016: 3.5%FY 2017: 12.8%FY 2018: 12.1%FY 2019: 10.2%FY 2020: 0.5%FY 2021: 21.4%FY 2022: 6.8%FY 2023: 53.3%FY 2024: 60.6%FY 2025: 16.7%
FY 2016 FY 2025
Operating Income 189.1%
FY 2016: -10.5%FY 2017: 5.0%FY 2018: 4.6%FY 2019: 1.6%FY 2020: -35.2%FY 2021: 54.3%FY 2022: 32.6%FY 2023: -41.6%FY 2024: 24.7%FY 2025: 189.1%
FY 2016 FY 2025
EPS (diluted) 422.7%
FY 2016: -7.7%FY 2017: 1.9%FY 2018: 40.0%FY 2019: -1.3%FY 2020: -33.6%FY 2021: 42.6%FY 2022: 28.5%FY 2023: -42.2%FY 2024: -29.9%FY 2025: 422.7%
FY 2016 FY 2025
Free Cash Flow 45.3%
FY 2016: 84.0%FY 2017: -17.4%FY 2018: 12.7%FY 2019: -17.0%FY 2020: 33.5%FY 2021: 62.3%FY 2022: -52.4%FY 2023: 58.2%FY 2024: 145.2%FY 2025: 45.3%
FY 2016 FY 2025

Financial Health

Current Ratio 4.3×
FY 2016: 6.4×FY 2017: 6.7×FY 2018: 6.6×FY 2019: 6.2×FY 2020: 6.8×FY 2021: 6.2×FY 2022: 6.2×FY 2023: 4.9×FY 2024: 2.5×FY 2025: 4.3×
FY 2016 5y median 4.9× FY 2025
Quick Ratio 2.7×
FY 2016: 5.0×FY 2017: 5.5×FY 2018: 5.2×FY 2019: 4.4×FY 2020: 4.9×FY 2021: 4.5×FY 2022: 4.3×FY 2023: 2.7×FY 2024: 1.8×FY 2025: 2.7×
FY 2016 5y median 2.7× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -0.5×
FY 2016: -0.3×FY 2017: -0.6×FY 2018: -0.6×FY 2019: -0.9×FY 2020: -1.3×FY 2021: -0.7×FY 2022: -0.5×FY 2023: 0.2×FY 2024: -0.5×FY 2025: -0.5×
FY 2016 5y median -0.5× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 39.6×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31